CLRB icon

Cellectar Biosciences
CLRB

Overview Fund Trends Analyst Outlook Journalist POV

35 hedge funds and large institutions have $30M invested in Cellectar Biosciences in 2024 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 9 increasing their positions, 10 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more capital invested

Capital invested by funds: $ → $

more ownership

Funds ownership: →

more funds holding in top 10

Funds holding in top 10: →

5% less funds holding

Funds holding: 37 → 35 (-2)

10% less repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 10

29% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 7

Holders
35
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$184K
Puts
$81K
Net Calls
Net Calls Change

Top Buyers

1
+$2.07M
2
+$1.88M
3
+$728K
4
ACM
Altium Capital Management
New York
+$460K
5
Vanguard Group
Vanguard Group
Pennsylvania
+$349K

Top Sellers

1
-$375K
2
-$176K
3
-$111K
4
Citadel Advisors
Citadel Advisors
Florida
-$108K
5
Millennium Management
Millennium Management
New York
-$107K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$5.51K
27
$4.89K
28
$2.99K
29
$2.14K
30
$824
31
$648
32
$218
33
$86
34
$39
35
–
36
–
37
–
38
–
39
–
40
–
41
–
1
2